Cadenza Bio accelerates and supports the development of a new class of highly selective Estrogen Receptor targeted small molecules.
Cadenza Bio has raised $2.4M in total funding. The most recent round was Debt Financing. The last funding was announced in August 2025.
Cadenza Bio's investors include Cortado Ventures, Illinois Ventures, Plains Ventures, Boyd Street Ventures, Oklahoma Life Science Fund.
Cadenza Bio is headquartered in Oklahoma City, United States.
Cadenza Bio accelerates and supports the development of a new class of highly selective Estrogen Receptor targeted small molecules.
Cadenza Bio is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cadenza Bio — Funding & Investors." VCBacked, August 28, 2025, https://www.vcbacked.co/company/cadenza-bio. Accessed August 13, 2026.
VCBacked. (2025). Cadenza Bio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/cadenza-bio
{{cite web |title=Cadenza Bio — Funding & Investors |url=https://www.vcbacked.co/company/cadenza-bio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated